Arsham Sheybani, MD

Joseph Panarelli, MD, and Arsham Sheybani, MD, discuss the Primary Trabeculectomy for Advanced Glaucoma: Pragmatic Multicentre Randomized Controlled Trial, or TAGS trial, and how this can apply to real world situation. This multicenter randomized controlled trial evaluated whether primary trabeculectomy or primary medical treatment leads to improved outcomes in terms of quality of life, clinical effectiveness, and safety.

Arsham Sheybani, MD, offers insight on how his glaucoma patient management protocols have altered and the shift in subconjunctival surgery in light of the pandemic.

The XEN Gel Stent is a micro-fistula implant designed to lower IOP without relying on physiologic outflow pathways – it connects the anterior chamber to the subconjunctival space. Prospective data from more than 900 surgeries from around the world support the safety and efficacy of this device.